| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/13/2011 | EP2307397A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 04/13/2011 | EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 04/13/2011 | EP2307385A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 04/13/2011 | EP2307368A1 Compound comprising phenyl pyridine units |
| 04/13/2011 | EP2307344A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 04/13/2011 | EP2306828A1 Prolyl hydroxylase inhibitors |
| 04/13/2011 | EP2306826A1 Salts of methyl 2-((r))-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate |
| 04/13/2011 | EP1818332B1 Process for producing epoxytriazole derivative |
| 04/13/2011 | EP1548005B1 Process for producing 2-substituted pyridine derivative |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015691A Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors |
| 04/13/2011 | CN102015686A Novel heterocyclic compounds and uses therof |
| 04/13/2011 | CN102015661A Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 04/13/2011 | CN102015660A 2-aminoquinazoline derivative |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015650A 2-aminoquinoline derivatives as 5-HT(5A) receptor antagonists |
| 04/13/2011 | CN102015582A Processes for preparing enantiomerically pure diol and dioxolane compounds |
| 04/13/2011 | CN102010373A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/13/2011 | CN102010281A Preparation method of alpha-acyloxy ether |
| 04/13/2011 | CN101448503B Piperidine and piperazine derivatives |
| 04/13/2011 | CN101239945B Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 04/13/2011 | CN101151246B 1-benzylindole-2-carboxamide derivatives |
| 04/13/2011 | CN101115743B Novel processes for the preparation of a 2H-chromene |
| 04/12/2011 | US7923562 Photocleavable linker methods and compositions |
| 04/12/2011 | US7923558 Method for obtaining pure tetrahydrocannabinol |
| 04/12/2011 | US7923467 Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| 04/12/2011 | US7923461 TNF-α production inhibitors |
| 04/12/2011 | US7923457 Quinoline derivatives |
| 04/12/2011 | CA2528496C Acylated amino acid amidyl pyrazoles and related compounds |
| 04/12/2011 | CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/07/2011 | WO2011040607A1 Aromatic amine derivative, and organic electroluminescent element |
| 04/07/2011 | WO2011039759A1 A new process for the preparation of lapatinib and its pharmaceutically acceptable salts |
| 04/07/2011 | WO2011039715A1 Novel ligands for sensitizing dyes of dye-sensitized solar cells |
| 04/07/2011 | WO2011039353A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/07/2011 | WO2011039130A1 New benzimidazole derivatives and their use as fxr agonists |
| 04/07/2011 | WO2010111436A3 Antiviral compounds and uses thereof |
| 04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
| 04/07/2011 | WO2010088455A3 Cromolyn derivatives and related methods of imaging and treatment |
| 04/07/2011 | WO2009146910A8 4, 6-diphenylpyrid-2-0nes against cancer |
| 04/07/2011 | US20110082163 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | US20110082132 [4-(1-amino-ehtyl) - cyclohexyl] -methyl-amine and [6-(1-amino-ehtyl) -tetrahydro-pyran-3-yl] -methyl-amine derivatives as antibacterials |
| 04/07/2011 | CA2776351A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/07/2011 | CA2772815A1 New benzimidazole derivatives and their use as fxr agonists |
| 04/06/2011 | EP2305808A1 Templated molecules and methods for using such molecules |
| 04/06/2011 | EP2305674A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 04/06/2011 | EP2305668A1 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators |
| 04/06/2011 | EP2305664A1 Anabaseine derivatives useful in the treatment of neurodegeneratives diseases |
| 04/06/2011 | EP2305655A2 Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators. |
| 04/06/2011 | EP2305651A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/06/2011 | EP2305648A1 Amide derivatives useful as glucokinase activators |
| 04/06/2011 | EP2305645A1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 04/06/2011 | EP2305643A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/06/2011 | EP2305641A1 Sulfonamide compound or salt thereof |
| 04/06/2011 | EP2305637A2 Substituted tetracycline compounds |
| 04/06/2011 | EP2305254A1 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists for the treatment of gatrointestinal conditions |
| 04/06/2011 | EP2305250A1 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/06/2011 | EP2303863A1 5- and 6-membered heterocyclic compounds |
| 04/06/2011 | EP2303861A1 Pyridine compounds |
| 04/06/2011 | EP2303860A2 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors |
| 04/06/2011 | EP1934174B1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/06/2011 | EP1814849B1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/06/2011 | EP1628968B1 4-imidazolin-2-one compounds |
| 04/06/2011 | EP1362852B1 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN102007122A Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 04/06/2011 | CN102007120A Fungicide hydroximoyl-heterocycles derivatives |
| 04/06/2011 | CN102007118A Pyrrolidinone glucokinase activators |
| 04/06/2011 | CN102007105A 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 04/06/2011 | CN102007102A Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 04/06/2011 | CN102007100A Compounds and compositions as modulators of GPR119 activity |
| 04/06/2011 | CN102002038A Ligustrazine nitrogen (oxygen) heteroatom alkylation derivative as well as preparation method and application thereof |
| 04/06/2011 | CN102001990A Heteroarylamine compounds, organic luminescence devices and panel display devices |
| 04/06/2011 | CN102001989A Heteroarylamine compounds, organic light-emitting devices and panel display devices |
| 04/06/2011 | CN102001987A Heteroarylamine compound, organic light-emitting device and panel display device |
| 04/06/2011 | CN101391995B Water-soluble paclitaxel ester compounds containing 1,2,3-triazole and preparation method |
| 04/06/2011 | CN101245046B 3-indole-1-propylene compounds, process for synthesizing 3-indole-1-propylene compounds and uses thereof |
| 04/06/2011 | CN101198328B Solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 04/06/2011 | CN101151249B 环戊吡啶及四氢喹啉衍生物 Cyclopentyl and tetrahydro-quinoline derivatives of pyridine |
| 04/05/2011 | US7919615 Route to formyl-porphyrins |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919524 Compounds, compositions and methods |
| 04/05/2011 | US7919509 2-oxochromene derivatives |
| 04/05/2011 | US7919508 3-piperidinylisochroman-5-ols as dopamine agonists |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919506 Dibenzyl amine compounds and derivatives |
| 04/05/2011 | US7919490 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/05/2011 | US7919488 Therapeutic compounds |
| 04/05/2011 | CA2598536C Oxyindole derivatives as 5ht4 receptor agonists |
| 04/05/2011 | CA2537127C Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2344168C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 03/31/2011 | WO2011036130A1 Indole derivatives as crac modulators |
| 03/31/2011 | WO2011035540A1 4-(substituted anilino)quinazoline derivatives as tyrosine kinase inhibitors |
| 03/31/2011 | WO2011035416A1 Hsp90 modulating compounds, compositions, methods and uses |